Anti-DNA and antiphospholipid antibodies in IVIG preparations: In vivo study in naive mice

Journal of Clinical Immunology

Volumn 18, Issue 1, 1998, Pages 52-60

  Krause, Ilan ^a,b   Blank, Miri ^a,b   Shoenfeld, Yehuda ^a,b  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Anti DNA antibodies; Antiphospholipid antibodies; Autoimmunity; Intravenous immunoglobulins

Indexed keywords

ANTIIDIOTYPIC ANTIBODY; AUTOANTIBODY; CARDIOLIPIN ANTIBODY; DNA ANTIBODY; DOUBLE STRANDED DNA; HISTONE ANTIBODY; IMMUNOGLOBULIN; IMMUNOGLOBULIN F(AB')2 FRAGMENT; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLINOSITOL; PHOSPHATIDYLSERINE; PHOSPHOLIPID ANTIBODY; SINGLE STRANDED DNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN BINDING; ARTICLE; AUTOIMMUNE DISEASE; BINDING AFFINITY; CONTROLLED STUDY; DRUG FORMULATION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FETUS RESORPTION; IMMUNIZATION; IN VIVO STUDY; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; PROTHROMBIN TIME; THROMBOCYTOPENIA;

EID: 0031889527     PISSN: 02719142     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1023239904856     Document Type: Article

References (64)

1. Greenberg AH: Antibodies and natural immunity. Biomed Pharmacother 39:4-6, 1985
2. Shoenfeld Y, Isenberg DA (eds): Natural Autoantibodies, Their Physiological Role and Regulatory Significance. Boca Raton, FL, CRC Press. 1993
3. Shoenfeld Y, Isenberg DA: The Mosaic of Autoimmunity, the Factors Associated with Autoimmune Diseases. Amsterdam, Elsvier. 1989
4. Shoenfeld Y: Pathogenic natural autoantibodies. Isr J Med Sci 29:42-145, 1992
5. Tincani A, Balesterieri G, Allegri F, Cattaneo R, Fornasieri A, Sinico A, D'Amico G: Induction of experimental SLE in naive mice by immunization with human polyclonal anti-DNA antibody carrying the 16/6 idiotype. Clin Exp Rheumatol 11:129-134, 1994
6. Dang H, Noriyoshi O, Takei M, Lazaridis K, Talal N: Induction of lupus associated autoantibodies by immunization with native and recombinant Ig peptides expressing a cross-reactive idiotype 4B4. J Immunol 151:7260-7267, 1993
7. Rombach E, Stetler DA, Brown JC: Rabbits produce SLE-like anti-RNA polymerase I and anti-DNA autoantibodies in responses to immunization with either human or murine SLE anti-DNA antibodies. Autoimmunity 13:291-302, 1992
8. Mendelovic S, Brocke S, Shoenfeld Y, Ben-Bassat M, Meshorer A, Bakimer R, Mozes E: Induction of SLE like disease in mice by a common anti-DNA idiotype. Proc Natl Acad Sci USA 85:2260-2264, 1988
9. Blank M, Krup M, Mendelovic S, Fricke H, Mozes E, Talal N, Coates ARM, Shoenfeld Y: The importance of the pathogenic 16/6 idiotype in the induction of SLE in naive mice. Scand J Immunol 31:45-52, 1990
10. Blank M, Mendelovic S, Mozes E, Shoenfeld Y: Induction of SLE like disease in naive mice with a monoclonal anti-DNA antibody derived from a patient with polymyositis carrying 16/6 Id. J Autoimmun 1:683-689, 1988
11. Branch DW, Dudley DJ, Mitchell MD, Abbott KA, Hammond E, Dayness RA: Immunoglobulin G fraction from patients with anti-phospholipid antibodies causes fetal death in Balb/c mice: A model for autoimmune fetal loss. Am J Obstet Gynecol 163:210-217, 1990
12. Blank M, Cohen J, Toder V, Shoenfeld Y: Induction of primary anti-phospholipid syndrome by anti-cardiolipin antibodies. Proc Natl Acad Sci USA 88:3069-3073, 1991
13. Bakimer R, Fishman P, Blank M, Sredni B, Djaldetti M, Shoenfeld Y: Induction of primary anti-phospholipid syndrome in mice by immunization with human monoclonal anti-cardiolipin antibody (H-3). J Clin Invest 89:1558-1563, 1992
14. Blank M, Tincani A, Shoenfeld Y: Induction of experimental anti-phospholipid syndrome in naive mice with purified IgG anti-phosphatidylserine antibodies. J Rheumatol 21:100-104, 1994
15. Blank M, Krause I, Ben-Bassat M, Shoenfeld Y: Induction of experimental anti-phospholipid syndrome associated with SLE following immunization with human monoclonal pathogenic anti-DNA idiotype. J Autoimmun 5:495-502, 1992
16. Cohen J, Bakimer R, Blank M, Valesini G, Shoenfeld Y: Pathogenic natural anti-cardiolipin antibodies: The experience from monoclonal gammopathy. Clin Exp Immunol 97:181-186, 1994
17. Jerne NK: Toward a network theory of the immune system. Ann Immunol 125:373-389, 1974
18. Jerne NK, Roland J, Cazenava PA: Recurrent idiotypes and internal images. EMBO J 1:243-247, 1982
19. Shoenfeld Y: Idiotypic induction of autoimmunity: A new aspect of the idiotypic network. FASEB J 8:1296-1301, 1994
20. Tomer Y, Gilburd B, Blank M, Lider O, Hershkoviz R, Fishman P, Zigelman R, Meroni PL, Wiik A, Shoenfeld Y: Characterization of biologically active antineutrophil cytoplasmic antibodies induced by mice. Arth Rheum 38:1375-1381, 1995
21. Blank M, Tomer Y, Stein M, Kopolovic J, Wiik A, Meroni PL, Conforty G, Shoenfeld Y: Immunization with anti-neutrophil cytoplasmic antibody (ANCA) induces the production of mouse ANCA and perivascular lymphocyte infiltration. Clin Exp Immunol 102:120-130, 1995
22. Berkman SA, Lee ML, Gale RP: Clinical uses of intravenous immunoglobulins. Semin Hematol 25:140-158, 1988
23. Arsura EL, Bick A, Brunner NG, Grob D: Effects of repeated doses of intravenous immunoglobulin in myasthenia gravis. Am J Med Sci 295:438-443, 1988
24. Jayne DRW, Davies M, Fox C, Lockwood CM: Treatment of systemic vasculitis with pooled intravenous immunoglobulin. Lancet 2:1137-1139, 1991
25. Bakimer R, Guilbrud B, Zurgil N, Shoenfeld Y: The effect of intravenous-globulin on the induction of experimental anti-phospholipid syndrome. Clin Immunol Immunopathol 69:97-102, 1993
26. Parker A: The role of IVIG in the management of patients with antiphospholipid antibodies and recurrent pregnancy losses. Clin Rev Allergy 10:105-118, 1992
27. Akashi K, Nagasawa K, Myumi T, Yokota E, Oochi N, Jusaba T: Successful treatment of refractory systemic lupus erythematosus with intravenous immunoglobulins. J Rheumatol 17:375-379, 1990
28. Tomer Y, Shoenfeld Y: Successful treatment of psychosis secondary to SLE with high dose intravenous immunoglobulin. Clin Exp Rheumatol 10:391-393, 1992
29. Schroeder JO, Zeuner RA, Euler HH, Loffler H: High dose intravenous immunoglobulins in systemic lupus erythematosus: Clinical and serological results of a pilot study. J Rheumatol 23:71-75, 1996
30. Fehr J, Hoffmaan V, Kappeler U: Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by high dose intravenous immunoglobulin. N Engl J Med 306:1254-1258, 1982
31. Achiron A, Margalit R, Hershkoviz R: Intravenous immunoglobulin treatment of experimental T cell-mediated autoimmune disease. J Clin Invest 93:600-605, 1994
32. Andersson U, Bojork L, Skanson-Saphir U, Andersson J: Pooled human IgG modulates cytokine production in lymphocytes and monocytes. Immunol Rev 139:5-20, 1994
33. Dietrich G, Kazatchkine MD: Normal immunoglobulin G (IgG) for therapeutic use (intravenous Ig) contain antiidiotypic specificities against an immunodominant, disease-associated, cross-reactive idiotype of human anti-thyroglobulin autoantibodies. J Clin Invest 85:620-625, 1990
34. Rossi F, Jayne DR, Lockwood CM, Kazatchkine MD: Anti-idiotypes against anti-neutrophil cytoplasmic antigen autoantibodies in normal human polyspecific IgG for therapeutic use and in the remission sera of patients with systemic vasculitis. Clin Exp Immunol 83:298-303, 1991
35. Kazatchkine MD, Rossi F, Sultan Y, Nydegger UE: Anti-idiotypes against autoantibodies to procoagulant factor VIII in IVIG. Int Rev Immunol 5:157-163, 1989
36. Rossi F, Kazatchkine MD: Antiidiotypes against autoantibodies in pooled normal human polyspecific Ig. J Immunol 143:4104-4109, 1989
37. Evans MJ, Suenaga R, Abdou NI: Detection and purification of antiidiotypic antibodies against anti-DNA in intravenous immune globulin. J Clin Immunol 11:291-295, 1991
38. Silvestris F, Cafforio P, Dammacco F: Pathogenic anti-DNA idiotype-reactive IgG in intravenous immunoglobulin preparations. Clin Exp Immunol 97:19-25, 1994
39. Berchtold P, Dale GL, Tani P, McMillan R: Inhibition of autoantibody binding to platelet glycoprotein IIb/IIIa by anti-idiotypic antibodies in intravenous gammaglobulin. Blood 74:2414-2417, 1989
40. Ayliffe W, Haeney M, Roberts SC, Lavin M: Uveitis after antineutrophil cytoplasmic antibody contamination of immunoglobulin replacement therapy. Lancet 339:558-559, 1992 (letter).
41. Vogele C, Andrassy K, Schmidbauer JM, Krastel H, Adler D, Ritz E: Retinal vasculitis and uveitis - An adverse reaction to intravenous immunoglobulin? Nephron 67:363, 1994
42. Brox AG, Cournoyer D, Sternbach M. Sprull G: Hemolytic anemia following intravenous gammaglobulin administration. Am J Med 93:114-115, 1993
43. Comenzo RL, Malachowski ME, Meissner HC, Fulton DR, Berkman EM: Immune hemolysis, disseminated intravascular coagulation and serum sickness after large dose of immune globulin given intravenously for Kawasaki disease. J Pediatr 120:926-928, 1992
44. Parham P: Preparation and purification of active fragments from mouse monoclonal antibodies. In Handbook of Experimental Immunology, Vol 2. Cellular Immunology, L Herzenberg, C Blackwell, L Herzenberg (eds). Oxford, Blackwell Scientific, p 14
45. Pullen GRM, Fitzgerald MG, Hoshing CS: Antibody avidity determination by ELISA using thiocyanate elution. J Immunol Methods 86:83-87, 1986
46. MacDonald RA, Hoshing CS, Jones CL: The measurement of relative antibody affinity by ELISA using thiocyanate elution. J Immunol Methods 106:191-194, 1988
47. Hohmann A, Comacchio R, Boswarva V, Sutjita M, Bradley J: The H-3 anti-phospholipid idiotype is found in patients with SLE but not in patients with syphilis. Clin Exp Immunol 86:207-211, 1989
48. Krause I, Blank M, Kopolovic J, Afek A, Goldberg I, Tomer Y, Shoenfeld Y: Abrogation of experimental systemic lupus erythematosus and primary antiphospholipid syndrome with intravenous gamma globulin. J Rheumatol 22:1068-1074, 1995
49. Gleicher N, Harlow BS: Commercial IgG immunoglobulin preparations exhibit IgG and IgA autoantibody reactivity at pharmacologic but not at physiologic concentrations. Mt. Sinai J Med 57:242-248, 1990
50. Saenko VA, Kabakov AE, Poverenny AM: Hidden high-avidity anti-DNA antibodies occur in normal human gammaglobulin preparations. Immunol Lett 34:1-5, 1992
51. Adib M, Ragimbeau J, Avrameas S, Ternynck T: IgG autoantibody activity in normal mouse serum is controlled by IgM. J Immunol 145:3807-3813, 1990
52. Kra-Oz Z, Lorber M, Shoenfeld Y, Scharff Y: Inhibitor(s) of natural anti-cardiolipin autoantibodies. Clin Exp Immunol 93:265-268, 1993
53. Lorber M, Kra-Oz Z, Guilbrud B, Shoenfeld Y: Natural (antiphospholipid, -PDH, -DNA) autoantibodies and their physiologic serum inhibitors. Isr J Med Sci 31:31-35, 1995
54. Donatini B, Goetz J, Hauptmann G: Uveitis and antineutrophil cytoplasmic antibody in immunoglobulin. Lancet 339:1175-1176, 1992
55. Barton JC, Herrera GA, Galla JH, Bertoli LF, Work J, Koopman WJ: Acute cryoglobulinemic renal failure after intravenous infusion of gamma globulin. Am J Med 82:624-629, 1987
56. Tam DA, Morton LD, Stronek DF, Leshner RT: Neutropenia in a patient receiving intravenous immune globulin. J Neuroimmunol 64:175-178, 1996
57. Lassiter HA, Bibb KW, Bertolone SJ, Patel CC, Stronek DF: Neonatal immune neutropenia following the administration of intravenous immune globulin. Am J Pediatr Hematol Oncol 15: 120-123, 1993
58. Vassilev T, Gelin C, Kaveri SV, Zilber MT, Boumsell L, Kazatchkin MD: Antibodies to the CD5 molecule in normal human immunoglobulins for therapeutic use (IVIG). Clin Exp Immunol 92:369-372, 1993
59. Fishman P, Falach-Vaknin E, Zigelman R, Bakimer R, Sredni B, Djaldeti M, Shoenfeld Y: Prevention of fetal loss in experimental antiphospholipid syndrome by in vivo administration of recombinant interleukin-3. J Clin Invest 91:1834-1837, 1993
60. Shoenfeld Y, Fishman P: Role of IL-3 in the antiphospholipid syndrome. Lupus 3:259-261, 1994
61. Blank M, Mendlovic S, Mozes E, Coates ARM, Shoenfeld Y: Induction of systemic lupus erythematosus in naive mice with T-cell lines specific for human anti-DNA antibody SA-1 (16/6 Id+) and for mouse tuberculosis antibody TB/68 (16/6 Id+). Clin Immunol Immunopathol 60:471-483, 1991
62. Blank M, Krause I, Buskila D, Teitelbaum D, Kopolovic J, Afek A, Goldberg I, Shoenfeld Y: Bromocriptine immunomodulation of experimental SLE and primary anti-phospholipid syndrome via induction of nonspecific T suppressor cells. Cell Immunol 162: 114-122, 1995
63. Blank M, Ben-Bassat M, Shoenfeld Y: Modulation of SLE induction in naive mice by specific T cells with suppressor activity to pathogenic anti-DNA idiotype. Cell Immunol 137:474-486, 1991
64. Kazatchkin MD, Dietrich G, Hurez V, Ronda N, Bellon B, Rossi F, Kaveri SV: V Region-mediated selection of autoreactive repertoires by intravenous immunoglobulin. Immunol Rev 139:79-107, 1994